永胜医疗(01612.HK)公布2026年中期业绩,收入按年增加7.1%至约4.82亿港元,公司拥有人应占溢利达4354.8万港元,同比减少15.65%;基本每股盈利6.71港仙,中期股息每股2.0港仙。
本文源自:金融界AI电报
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.